» Articles » PMID: 38992068

Identification of Risk Factors of Long COVID and Predictive Modeling in the RECOVER EHR Cohorts

Abstract

Background: SARS-CoV-2-infected patients may develop new conditions in the period after the acute infection. These conditions, the post-acute sequelae of SARS-CoV-2 infection (PASC, or Long COVID), involve a diverse set of organ systems. Limited studies have investigated the predictability of Long COVID development and its associated risk factors.

Methods: In this retrospective cohort study, we used electronic healthcare records from two large-scale PCORnet clinical research networks, INSIGHT (~1.4 million patients from New York) and OneFlorida+ (~0.7 million patients from Florida), to identify factors associated with having Long COVID, and to develop machine learning-based models for predicting Long COVID development. Both SARS-CoV-2-infected and non-infected adults were analysed during the period of March 2020 to November 2021. Factors associated with Long COVID risk were identified by removing background associations and correcting for multiple tests.

Results: We observed complex association patterns between baseline factors and a variety of Long COVID conditions, and we highlight that severe acute SARS-CoV-2 infection, being underweight, and having baseline comorbidities (e.g., cancer and cirrhosis) are likely associated with increased risk of developing Long COVID. Several Long COVID conditions, e.g., dementia, malnutrition, chronic obstructive pulmonary disease, heart failure, PASC diagnosis U099, and acute kidney failure are well predicted (C-index > 0.8). Moderately predictable conditions include atelectasis, pulmonary embolism, diabetes, pulmonary fibrosis, and thromboembolic disease (C-index 0.7-0.8). Less predictable conditions include fatigue, anxiety, sleep disorders, and depression (C-index around 0.6).

Conclusions: This observational study suggests that association patterns between investigated factors and Long COVID are complex, and the predictability of different Long COVID conditions varies. However, machine learning-based predictive models can help in identifying patients who are at risk of developing a variety of Long COVID conditions.

Citing Articles

Risk of long covid in patients with pre-existing chronic respiratory diseases: a systematic review and meta-analysis.

Terry P, Heidel R, Wilson A, Dhand R BMJ Open Respir Res. 2025; 12(1).

PMID: 39884720 PMC: 11784193. DOI: 10.1136/bmjresp-2024-002528.


Coronavirus Disease 2019 (COVID-19) Real World Data Infrastructure: A Big-Data Resource for Study of the Impact of COVID-19 in Patient Populations With Immunocompromising Conditions.

Crawford J, Penberthy L, Pinto L, Althoff K, Assimon M, Cohen O Open Forum Infect Dis. 2025; 12(1):ofaf021.

PMID: 39850579 PMC: 11756308. DOI: 10.1093/ofid/ofaf021.


Current update on the neurological manifestations of long COVID: more questions than answers.

Stefanou M, Panagiotopoulos E, Palaiodimou L, Bakola E, Smyrnis N, Papadopoulou M EXCLI J. 2025; 23():1463-1486.

PMID: 39850323 PMC: 11755773. DOI: 10.17179/excli2024-7885.


The utility of personal wearable data in long COVID and personalized patient care.

Enichen E, Heydari K, Wang S, Nickel G, Kvedar J NPJ Digit Med. 2024; 7(1):326.

PMID: 39557995 PMC: 11573978. DOI: 10.1038/s41746-024-01341-z.


A short story of long COVID.

Kundi M Wien Klin Wochenschr. 2024; 136(21-22):587-589.

PMID: 39436440 DOI: 10.1007/s00508-024-02453-y.


References
1.
Sudre C, Murray B, Varsavsky T, Graham M, Penfold R, Bowyer R . Attributes and predictors of long COVID. Nat Med. 2021; 27(4):626-631. PMC: 7611399. DOI: 10.1038/s41591-021-01292-y. View

2.
Moreno-Perez O, Merino E, Leon-Ramirez J, Andres M, Ramos J, Arenas-Jimenez J . Post-acute COVID-19 syndrome. Incidence and risk factors: A Mediterranean cohort study. J Infect. 2021; 82(3):378-383. PMC: 7802523. DOI: 10.1016/j.jinf.2021.01.004. View

3.
Kuodi P, Gorelik Y, Zayyad H, Wertheim O, Beiruti Wiegler K, Abu Jabal K . Association between BNT162b2 vaccination and reported incidence of post-COVID-19 symptoms: cross-sectional study 2020-21, Israel. NPJ Vaccines. 2022; 7(1):101. PMC: 9411827. DOI: 10.1038/s41541-022-00526-5. View

4.
Fleurence R, Curtis L, Califf R, Platt R, Selby J, Brown J . Launching PCORnet, a national patient-centered clinical research network. J Am Med Inform Assoc. 2014; 21(4):578-82. PMC: 4078292. DOI: 10.1136/amiajnl-2014-002747. View

5.
Brentnall A, Cuzick J . Use of the concordance index for predictors of censored survival data. Stat Methods Med Res. 2016; 27(8):2359-2373. PMC: 6041741. DOI: 10.1177/0962280216680245. View